These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1628364)

  • 1. Reversal of multidrug resistance by phenothiazines and structurally related compounds.
    Ramu A; Ramu N
    Cancer Chemother Pharmacol; 1992; 30(3):165-73. PubMed ID: 1628364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of multidrug resistance by bis(phenylalkyl)amines and structurally related compounds.
    Ramu A; Ramu N
    Cancer Chemother Pharmacol; 1994; 34(5):423-30. PubMed ID: 8070010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
    Ford JM; Prozialeck WC; Hait WN
    Mol Pharmacol; 1989 Jan; 35(1):105-15. PubMed ID: 2563302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenothiazines and structurally related compounds as modulators of cancer multidrug resistance.
    Tsakovska I; Pajeva I
    Curr Drug Targets; 2006 Sep; 7(9):1123-34. PubMed ID: 17017890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of phenothiazines with lipid bilayer and their role in multidrug resistance reversal.
    Michalak K; Wesolowska O; Motohashi N; Molnar J; Hendrich AB
    Curr Drug Targets; 2006 Sep; 7(9):1095-105. PubMed ID: 17017888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR and 3D-QSAR of phenothiazine type multidrug resistance modulators in P388/ADR cells.
    Tsakovska IM
    Bioorg Med Chem; 2003 Jul; 11(13):2889-99. PubMed ID: 12788359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines.
    Ford JM; Bruggemann EP; Pastan I; Gottesman MM; Hait WN
    Cancer Res; 1990 Mar; 50(6):1748-56. PubMed ID: 1968358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design and pre-clinical pharmacology of drugs for reversing multidrug resistance.
    Hait WN; Aftab DT
    Biochem Pharmacol; 1992 Jan; 43(1):103-7. PubMed ID: 1346493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
    Molnár J; Hevér A; Fakla I; Fischer J; Ocsovski I; Aszalós A
    Anticancer Res; 1997; 17(1A):481-6. PubMed ID: 9066699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance reversing activity of newly developed phenothiazines on P-glycoprotein (ABCB1)-related resistance of mouse T-lymphoma cells.
    Spengler G; Takács D; Horváth A; Riedl Z; Hajós G; Amaral L; Molnár J
    Anticancer Res; 2014 Apr; 34(4):1737-41. PubMed ID: 24692704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic potential of phenothiazines.
    Motohashi N; Kawase M; Satoh K; Sakagami H
    Curr Drug Targets; 2006 Sep; 7(9):1055-66. PubMed ID: 17017885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1.
    Wesołowska O
    Acta Biochim Pol; 2011; 58(4):433-48. PubMed ID: 22187677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The primary in vitro antitumor screening of "half-mustard type" phenothiazines.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Nacsa J; Molnár J
    Anticancer Res; 1997; 17(5A):3409-23. PubMed ID: 9413180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of multidrug resistance in mouse lymphoma cells by phenothiazines.
    Molnar J; Molnar A; Mucsi I; Pinter O; Nagy B; Varga A; Motohashi N
    In Vivo; 2003; 17(2):145-9. PubMed ID: 12792975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of calculated molecular orbital energies of some phenothiazine compounds with MDR reversal properties.
    Hilgeroth A; Molnár A; Molnár J; Voigt B
    Eur J Med Chem; 2006 Apr; 41(4):548-51. PubMed ID: 16516350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biochemical characterization of new phenothiazines and related drugs as MDR reversal agents.
    Schmidt M; Teitge M; Castillo ME; Brandt T; Dobner B; Langner A
    Arch Pharm (Weinheim); 2008 Oct; 341(10):624-38. PubMed ID: 18816589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between biological activity and dipole moment in benzo[a]phenothiazines.
    Motohashi N; Kurihara T; Yamanaka W; Satoh K; Sakagami H; Molnár J
    Anticancer Res; 1997; 17(5A):3431-5. PubMed ID: 9413182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling of phenothiazines and related drugs as multidrug resistance modifiers: a comparative molecular field analysis study.
    Pajeva I; Wiese M
    J Med Chem; 1998 May; 41(11):1815-26. PubMed ID: 9599232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds.
    Molnár J; Szabo D; Mándi Y; Mucsi I; Fischer J; Varga A; König S; Motohashi N
    Anticancer Res; 1998; 18(4C):3033-8. PubMed ID: 9713505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.